About: SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Creator	Widmer, Andreas Kuster, Gabriela Zhou, Qian Osswald, Stefan Burkard, Thilo Haaf, Philip Pfister, Otmar Twerenbold, Raphael
Source	Medline; PMC
abstract	covid:d1ac495575a4d87477fa1371b141da03864c4cd5#abstract
has issue date	2020-03-20(xsd:dateTime)
bibo:doi	10.1093/eurheartj/ehaa235
bibo:pmid	32196087
has license	cc-by-nc
sha1sum (hex)	d1ac495575a4d87477fa1371b141da03864c4cd5
schema:url	https://doi.org/10.1093/eurheartj/ehaa235
resource representing a document's title	SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
has PubMed Central identifier	PMC7184407
has PubMed identifier	32196087
schema:publication	Eur Heart J
resource representing a document's body	covid:d1ac495575a4d87477fa1371b141da03864c4cd5#body_text
is schema:about of	named entity 'translational' named entity 'evidence' named entity 'angiotensin-converting enzyme (ACE) inhibitors' named entity '2019' named entity 'INTAKE' named entity 'ACE2' named entity 'RAAS' named entity 'INHIBITION' named entity 'rapid' named entity 'response' named entity 'infected' named entity 'COVID-19' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'COVID' named entity 'up-regulating' named entity 'British Medical Journal' named entity 'RAAS' named entity 'Corona virus disease 2019' named entity 'COVID-19' named entity 'RAAS' named entity 'viral load' named entity 'ACE' named entity 'British Medical Journal' named entity 'cardiovascular diseases' named entity 'receptor' named entity 'angiotensin II' named entity 'severe acute respiratory syndrome' named entity 'RAAS' named entity 'ACE2' named entity 'RAAS' named entity 'up-regulation' named entity 'pulmonary disease' named entity 'Alnylam' named entity 'COVID' named entity 'hypertension' named entity 'Ang II' named entity 'ACE2' named entity 'Lung' named entity 'angiotensin II' named entity 'angiotensin II receptor type 1' named entity 'up-regulation' named entity 'Boehringer Ingelheim' named entity 'ARBs' named entity 'O.P.' named entity 'COVID-19' named entity 'cardiovascular disease' named entity 'ACE2' named entity 'heart failure' named entity 'causal relationship' named entity 'Ang1' named entity 'tested positive for COVID-19' named entity 'SARS-CoV' named entity 'receptor' named entity 'cardiovascular disease' named entity 'rapid response' named entity 'RAAS' named entity 'ACE2' named entity 'viral load' named entity 'Sanofi' named entity 'reverse causality' named entity 'Astra Zeneca' named entity 'co-factors' named entity 'SARS-CoV2' named entity 'RAAS' named entity 'risk factor' named entity 'RAAS' named entity 'Corona virus disease 2019' named entity 'ACE' named entity 'renin-angiotensin-aldosterone' named entity 'RAAS' named entity 'ACE-I' named entity 'COVID' named entity 'heart failure' named entity 'SARS-CoV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software